Form 4: ICU Medical COO Exercises Stock Options and Sells Shares in May 2025

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, exercised stock options and subsequently sold a portion of the acquired shares over two days in May 2025.

Summary

• Christian B. Voigtlander, Chief Operating Officer of ICU Medical Inc. (ICUI), conducted transactions involving the company's common stock on May 22 and May 23, 2025.
• On May 22, 2025, Mr. Voigtlander exercised 5,555 non-qualified stock options at an exercise price of $96.83 per share.
• Following the option exercise on May 22, 2025, he sold 4,959 shares of common stock at an average price of $130.0327 per share.
• On May 23, 2025, Mr. Voigtlander again exercised 5,555 non-qualified stock options at an exercise price of $96.83 per share.
• Subsequent to this second exercise on May 23, 2025, he sold an additional 4,959 shares of common stock at an average price of $130.00 per share.
• After these reported transactions, Mr. Voigtlander directly beneficially owned 4,903 shares of common stock and 11,115 non-qualified stock options.
• The options exercised were granted on June 4, 2016, and are set to expire on June 4, 2025.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction filing (Form 4) which reports an executive's exercise of stock options and subsequent sale of shares. It does not inherently convey positive or negative sentiment about the company's performance or outlook, as such sales are often for personal financial planning or tax purposes.

Positives

• The sale price of the shares ($130.0327 and $130.00) is notably higher than the exercise price of the options ($96.83), indicating a profitable transaction for the insider.
• The transactions represent the monetization of previously granted equity compensation, which is a standard part of executive remuneration.

Negatives

• The sale of shares by a Chief Operating Officer, while common for tax and liquidity purposes, reduces the executive's direct equity stake in the company, which some investors might interpret as a slight reduction in direct alignment of interests.

Future Outlook

This Form 4 filing is a report of historical insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The document is a standard SEC Form 4 filing reporting insider transactions and does not contain direct quotes or paraphrased statements from company management beyond the signature of the attorney-in-fact.

Industry Context

Insider transactions, such as option exercises and subsequent share sales, are common occurrences across all industries, including the medical device sector where ICU Medical operates. These transactions typically reflect an executive's personal financial planning, including liquidity needs or tax obligations related to equity compensation, rather than a direct commentary on the company's operational performance or broader industry trends.

Comparison to Industry Standards

• This document reports routine insider transactions. There are no specific company or project results to compare against global benchmarks or specific comparable companies. The transactions themselves are standard for executive compensation plans involving stock options in publicly traded companies.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive might be viewed with slight caution by some, though it is a common practice for tax and liquidity purposes following option exercises. The fact that the sale price is higher than the exercise price indicates a gain for the executive, which could be seen as a positive reflection of the stock's value at the time of sale.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The document itself does not outline future actions or milestones for the company, as it is a historical report of insider trading activity.

Key Dates

Keywords

ICU Medical, ICUI, Form 4, Insider Trading, Stock Options, Share Sale, Christian B. Voigtlander, Chief Operating Officer, Beneficial Ownership, Equity Compensation